Psoriasis after treatment of juvenile idiopathic arthritis with etanercept

被引:30
|
作者
Peek, R.
Scott-Jupp, R.
Strike, H.
Clinch, J.
Ramanan, A. V.
机构
[1] Royal Natl Hosp Rheumat Dis, Bristol, Avon, England
[2] N Bristol NHS Trust, Dept Paediat Rheumatol, Bristol, Avon, England
[3] Salisbury Dist Gen Hosp, Dept Paediat, Salisbury, Wilts, England
关键词
D O I
10.1136/ard.2005.049916
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1259 / 1259
页数:1
相关论文
共 50 条
  • [41] Safety of etanercept for treatment of juvenile idiopathic arthritis (JIA) - Data of the German etanercept JIA registry
    Hornett, G
    Kuester, R
    Girschick, H
    Foeldvari, I
    Moebius, D
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 72 - 72
  • [42] Bone mineral density improvement after one year of treatment with etanercept in patients with juvenile idiopathic arthritis
    G Susic
    R Stojanovic
    N Damjanov
    J Vojinovic
    G Vijatov
    [J]. Pediatric Rheumatology, 6 (Suppl 1)
  • [43] Effectiveness and compatibility of etanercept and methotrexate or etanercept for patients with juvenile idiopathic arthritis
    De Bock, F.
    Foeldvari, I.
    Girschick, H. J.
    Kuester, R.
    Michels, H.
    Moebius, D.
    Schmeling, H.
    Horneff, G.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 (07): : 628 - 629
  • [44] Etanercept in the treatment of psoriatic arthritis and psoriasis
    Kazuki Takada
    [J]. Arthritis Research & Therapy, 3 (1)
  • [45] Reaction on a fresh therapy with etanercept after therapy pause with juvenile idiopathic arthritis
    Napp, M.
    Foeldvari, I.
    Michels, H.
    Moebius, D.
    Horneff, G.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 (07): : 637 - 637
  • [46] Update upon efficacy and safety of etanercept for the treatment of spondyloarthritis and juvenile idiopathic arthritis
    Murdaca, Giuseppe
    Negrini, Simone
    Magnani, Ottavia
    Penza, Elena
    Pellecchio, Marco
    Gulli, Rossella
    Mandich, Paola
    Puppo, Francesco
    [J]. MODERN RHEUMATOLOGY, 2018, 28 (03) : 417 - 431
  • [47] Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients
    Southwood, Taunton R.
    Foster, Helen E.
    Davidson, Joyce E.
    Hyrich, Kimme L.
    Cotter, Catherine B.
    Wedderburn, Lucy R.
    Hull, Richard G.
    Venning, Helen E.
    Rahman, Joy K.
    Cummins, Carole L.
    [J]. RHEUMATOLOGY, 2011, 50 (01) : 189 - 195
  • [48] Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis
    Tynjala, Pirjo
    Lindahl, Paivi
    Honkanen, Visa
    Lahdenne, Pekka
    Kotaniemi, Kaisu
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (04) : 548 - 550
  • [49] Etanercept treatment improves longitudinal growth in prepubertal children with juvenile idiopathic arthritis
    Vojvodich, Paola Fernandez
    Hansen, Jes B.
    Andersson, Ulf
    Savendahl, Lars
    Hagelberg, Stefan
    [J]. JOURNAL OF RHEUMATOLOGY, 2007, 34 (12) : 2481 - 2485
  • [50] A combination of etanercept and methotrexate for the treatment of refractory juvenile idiopathic arthritis: a pilot study
    Schmeling, H
    Mathony, K
    John, V
    Keysser, G
    Burdach, S
    Horneff, G
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (04) : 410 - 412